Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.32 | 11.06 |
| PEG Ratio (TTM) | 1.12 | -0.50 |
| P/S Ratio (TTM) | 1.00 | 1.83 |
| P/B Ratio (TTM) | 4.64 | 2.24 |
| P/FCF Ratio (TTM) | 27.70 | 10.33 |
| Price to 5YR AVG Earnings Ratio | 24.48 | 15.87 |
| Price to 5YR AVG FCF Ratio | 58.63 | -31.34 |
Profitability (80%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 13.35% | 2.63% |
| ROE (TTM) | 31.74% | 7.59% |
| Net Profit Margin (TTM) | 6.10% | -2.43% |
| ROIC 5YR AVG | 86.17% | 7.48% |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 133.65% | 2,165.48% | 1,321.65% |
| Revenue | 0.70% | -0.90% | -2.91% |
| Net Income | 134.24% | 2,224.05% | 1,356.23% |
| Cash Flow | 27.23% | 44.84% | 52.61% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.60 | 0.83 |
| Quick Ratio (TTM) | 1.60 | 0.77 |
| D/E Ratio (TTM) | 0.01 | 1.44 |
| Interest Coverage (TTM) | N/A | 5.33 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 5.88 | 1.11 |
| LTL to 5YR AVG FCF | 0.07 | -9.52 |
| Shares Outstanding Growth 5YR AVG | -0.01% | 31.69% |